Press Releases & Presentations

 
(Swipe to view full table)
  Date Title and Summary View

Apr 10, 2016

Investor Overview

Jan 29, 2016

District Court Dismisses Lawsuit Against Accelerate Diagnostics
TUCSON, Ariz., Jan. 29, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) ("Accelerate Diagnostics") announced today that the United States District Court for the District of Arizona granted Accelerate Diagnostics' Motion to Dismiss the class action lawsuit filed against it in March of 2015. In granting the company's motion, the...Read more

Jan 5, 2016

Accelerate Diagnostics to Present at the J.P. Morgan 34th Annual Healthcare Conference on January 12th
TUCSON, Ariz., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced today that Lawrence Mehren, President and Chief Executive Officer, is scheduled to present at the J.P. Morgan 34th Annual Healthcare Conference in San Francisco, CA on Tuesday, January 12th at 7:30 AM PST / 10:30 AM EST. A live audio webcast...Read more

Dec 15, 2015

Accelerate Diagnostics Completes $109 Million Offering, Underwriters Exercise in Full Their Option to Purchase Additional Shares
TUCSON, Ariz., Dec. 15, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced that it completed a public offering of 6,426,471 shares of common stock today at a previously disclosed price per share of $17.00 which includes 838,235 shares issued and sold to the underwriters who exercised in full their option to purchase add...Read more

Dec 9, 2015

Accelerate Diagnostics Announces Pricing of Public Offering of Common Stock
TUCSON, Ariz., Dec. 9, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced the pricing of an underwritten public offering of 5,588,236 shares of its common stock at a price to the public of $17.00 per share. All of the shares are being sold by Accelerate Diagnostics. The gross proceeds to Accelerate Diagnostics from ...Read more

Dec 8, 2015

Accelerate Diagnostics Announces Proposed Public Offering of Common Stock
TUCSON, Ariz., Dec. 8, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced that it has commenced an underwritten public offering of $80 million of shares of its common stock. All of the shares are being offered by Accelerate Diagnostics. In addition, Accelerate Diagnostics expects to grant the underwriters of the off...Read more

Dec 2, 2015

Accelerate Diagnostics Reports Positive Results From Pilot Study of Its Investigational ID/AST System and Blood Culture Assay Kit and Initiation of Trial to Support FDA Clearance
TUCSON, Ariz., Dec. 2, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced positive findings from a multicenter pilot study to evaluate external performance of its ID/AST System and Blood Culture Assay Kit. Based on the results of the study, the company also announced the initiation of its clinical trial for submission to the U.S. Food ...Read more

Dec 1, 2015

Accelerate Diagnostics to Present at the 27th Annual Piper Jaffray Healthcare Conference on December 2, 2015
TUCSON, Ariz., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced today that Lawrence Mehren, Chief Executive Officer, is scheduled to present a corporate update at the Piper Jaffray Healthcare Conference in New York City, NY on Wednesday, December 2nd at 12:30 PM ET. About Accelerate Diagnostics, Inc. ...Read more

Aug 5, 2015

Accelerate Diagnostics to Present at the 35th Annual Canaccord Genuity Growth Conference on August 13, 2015
TUCSON, Ariz., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced today that Lawrence Mehren, Chief Executive Officer, is scheduled to present a corporate update ...Read more

Jun 30, 2015

Accelerate Diagnostics Achieves CE-IVD Milestone for ID/AST System and ID/AST Blood Culture Assay
TUCSON, Ariz., June 30, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc., announced today its declaration of conformity to the European In Vitro Diagnostic Directive 98/79 EC and CE Mark of the Accelerate ID/AST System and ID/AST Blood Culture Assay for in vitro diagnostic use. The Accelerate ID/AST System is a diagnostic platform providing ra...Read more
FirstPrevious
1
2
3
4
5
...
7
Next Last

= add release to Briefcase
NASDAQ: AXDX
$ 30.30
+0.75
(2.54%)
4:00 PM ET on Jun 22, 2017
Day High: 30.40
Day Low:  28.90
Volume:    435,013
Delayed ~20 min., by eSignal.

Want to receive investor-related news and updates?

Join our mailing list

Other updates